GEMFOS 35MG TABLET contains Risedronate, which belongs to a group of medicines called Bisphosphonates, which are used to manage bone diseases. It is used to manage osteoporosis in postmenopausal women, increase bone mass in men with osteoporosis, and manage osteoporosis in men and women that is caused by management with steroid medicine such as prednisone. It is also used to manage Paget's disease of the bone in men and women.

Osteoporosis is a bone disease that develops when bone mineral density and bone mass decrease or when the quality or structure of bone changes. This can lead to a decrease in bone strength, which can increase the risk of fracture (broken bone).

During postmenopausal osteoporosis, the bones become weaker, more fragile, and more likely to break after a fall or strain. Paget's disease is a chronic bone disorder that results in enlarged, deformed bones due to excessive breakdown and formation of bone tissue that can cause bones to weaken and may result in bone pain, arthritis, deformities, or fracture.

Before taking this medicine, tell your doctor if you have ever had heart disease or liver problems. GEMFOS 35MG TABLET is not recommended in patients with severe kidney diseases and low blood calcium levels. Consult your doctor for advice.

GEMFOS 35MG TABLET is not recommended for use in pregnant or breastfeeding women. Consult your doctor before taking it.

GEMFOS 35MG TABLET is not recommended for use in children and adolescents under 18 years of age. Consult your doctor before taking it.

The most common side effects of taking GEMFOS 35MG TABLET are indigestion, nausea, stomach pain or discomfort, constipation, feelings of fullness, bloating, diarrhea, pain in your bones, muscles, or joints, and headache. Consult your doctor if any of the side effects worsen.